Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT07700901
Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable symptoms. The main purpose of this research is to evaluate whether combining Electroacupuncture(EA) with a exercise training program works better than using electroacupuncture alone. Electroacupuncture uses gentle electrical pulses through acupuncture needles to stimulate nerves, while the exercise program aims to improve a patient's balance, physical strength, and movement safety. Participants will be randomly assigned to receive either the combination therapy or electroacupuncture alone. The study involves scheduled hospital visits along with home-based practice guided by instructional videos. The researchers aim to evaluate the efficacy of combined EA and exercise training program on neurological symptoms and quality of life in CIPN patients across different CTCAE grades.
Eligibility
Inclusion Criteria: 1. Confirmed cancer diagnosis with prior taxane or platinum-based chemotherapy. 2. CIPN symptoms staged as CTCAE Grade 1, 2, or 3. 3. Life expectancy \> 6 months and capable of independent ambulation. Exclusion Criteria: 1. Presence of a cardiac pacemaker. 2. Severe coagulation disorders. 3. Neuropathy from other etiologies (non-chemotherapy induced).
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07700901